#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Cerebral haemorrhage Turner's syndrome Heart disease congenital Plasma cell myeloma recurrent Antisynthetase syndrome Cholangiosarcoma Corneal neovascularisation Neuroendocrine carcinoma of the skin Propionic acidaemia Multifocal motor neuropathy Congenital generalised lipodystrophy B-cell small lymphocytic lymphoma refractory Cystic fibrosis lung Immunodeficiency congenital More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Life with Disease IgA nephropathy – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Hereditary angioedema – Treatment Noonan syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Treatment Glycogen storage disease type I – Trials in Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Lennox-Gastaut syndrome – Treatment Idiopathic inflammatory myopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Egl-001 Efzofitimod Dextrose Bp Selpercatinib Ttx-030 Isoniazid Toldc Cangrelor Tetrasodium Avalotcagene Ontaparvovec REGN7999 Islatravir Oteracil Onasemnogene Abeparvovec Aluminium Hydroxide Lasmiditan Betamethasone Dipropionate Dotatate Afimetoran Besilate Dihydrate Busulfan Hct116-A More therapies…

    Learn about Your Condition

    Bronchitis Kidney transplant rejection Alagille syndrome Hepatic adenoma Desmoplastic melanoma Breast cancer Lupus nephritis Generalised anxiety disorder Anxiety Lipid metabolism disorder Appendicitis Implantation complication Incontinence Fragile X syndrome Amyotrophic lateral sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Different Dosing Schedules of Irinotecan Hydrochloride, Calcium Folinate, and Fluorouracil in Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Fluorouracil
    Hungary

  • Comparison of Opioid-Free versus Opioid-Based General Anesthesia for Reducing Nausea and Vomiting After Robotic Bariatric Surgery in Obese Patients (ANGELO Study)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Magnesium Sulfate Heptahydrate
    • Lidocaine Hydrochloride
    Spain

  • Study to Examine Distribution of Aromatase Inhibitor and Ribociclib in ER+ HER2- Early Breast Cancer in Postmenopausal Women Scheduled for Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Letrozole
    • Ribociclib
    The Netherlands

  • Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftazidime
    France

  • Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Cyclophosphamide
    France

  • Evaluation of Mesenchymal Stem Cell Eye Injections for Dry Eye Disease in Patients with Graft-versus-Host Disease Who Haven’t Responded to Standard Treatments

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
    Spain
Previous Page
1 … 781 782 783 784 785 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!